Towards a European personalized registry for colorectal cancer patients: 919 patients have already enrolled!

About the project Download the brochure

What's New?

EORTC’s SPECTAcolor screening patients with colorectal cancer for efficient clinical trial access

in Media, Published Articles, Science

Capture100th

SPECTAcolor, the EORTC’s premier Screening Platform for Efficient Clinical Trial Access for patients with colorectal cancer, enrolled its 100th patient in February 2014. “We are satisfied with the recruitment of patients with colorectal cancer and the analyses of their tumors. Chaussures Nike Pas Cher air max 1 pas cher Our efforts will lead to the… Read more »

A booklet on Colorectal Cancer Facts and Figures in support of SPECTAcolor!

in Brochure, Media, Science

Capture

  A booklet on Colorectal Cancer Facts and Figures including country specific colorectal cancer statistics This booklet is now available for the following Walgreens Boots Alliance fundraising partnering countries: France, nike tn requin Nike Air Max Goedkoop Italy, Spain, cheap nike trainers uk Fjallraven Kanken Occasion The Netherlands, new balance 530 homme soldes Chaussure Adidas… Read more »

1 year in, SPECTAcolor is a viable cancer research model!

in Media

Gunnar-Folprecht-featured-image

The EORTC is pleased to announce the successful implementation of SPECTAcolor, ‘Screening Patients for Efficient Clinical Trial Access’ – the first Pan European collaborative molecular screening platform for colorectal cancer patients. SPECTAcolor proves the logistical feasibility of the infrastructure that was built to run next generation trials in a multinational setting. Now one year into… Read more »

The SPECTAcolor Biobank welcomes its 100th colorectal cancer patient in mid-February!

in Media, Published Articles, Science

iStock_000017000305Small

SPECTAcolor is the first tumour Biobank and biomarker analysis platform to test molecular alterations in colorectal cancer patients whose illness is spreading fast. Solde Adidas The aim of the Biobank is to develop personalized cancer treatments tested in the course of clinical trials. Today, the EORTC is proud to announce the enrolment of the 100th… Read more »

Clinical trials and more… Did you know that the first “clinical trial” dates back to 1747?

in Media, Press Releases, Published Articles, Science

Doctor listening to a patient at her practice

This quarterly edition is dedicated to clinical trials and what they are all about. But first let us provide you with a brief update on the project patients’ status of enrollment. Today, the EORTC is proud to announce that 208 patients have been enrolled in the biobank to be entered in biomarker-led clinical trials. Good… Read more »

Our project in detail: A SPECTAcolor presentation!

in Meetings, Science, Videos

egam_2013_web

A full account on the SPECTAcolor biobank given by Sabine Tejpar on 8 March 2013, nike blazer pas cher fjallraven kanken classic during the EORTC Groups Annual Meeting (EGAM), goedkope nike air max nike goedkoop is available on YouTube ! From the rationale of our project to the fundraising initiatives,